相关实验视频
Updated: Jul 19, 2025

07:24
Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
6.8K
这是一项分散的,前性的观察性研究,旨在从使用智能手机的骨髓灰质炎患者中收集真实世界的数据
Sandra Steyaert1,2, Meelis Lootus1, Chethan Sarabu1
1Sharecare, Inc., Atlanta, GA, United States.
Frontiers in neurology
|August 17, 2023
概括
这项研究表明,智能手机数据收集对肌痛性硬化症 (MG) 患者是可行的,识别数字标记物,如症状变化和活动水平,可以预测恶化.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 现实世界的数据
背景情况:
- 骨髓灰质炎 (MG) 是一种慢性自身免疫性神经肌肉疾病.
- 鉴别MG恶化对于有效管理至关重要.
- 当前的监测方法可能无法完全捕捉MG症状的动态性质.
研究的目的:
- 评估一个去中心化,基于智能手机的平台的可行性,用于收集MG患者的真实数据.
- 用患者报告的结果和可穿戴设备数据来描述MG恶化期间的症状参与.
主要方法:
- 一项为期3个月的前性研究招募了113名患有Myasthenia Gravis的参与者.
- 通过智能手机应用程序收集的数据包括每日电子患者报告结果 (ePRO) 和可选的可穿戴数据.
- MG-日常生活活动 (MG-ADL) 评分和恶化状态是主要终点.
主要成果:
- 该研究成功地招募并监测了美国各地的参与者,完成率为73%.
- 分析显示MG-ADL得分与恶化状态之间的一致性.
- 数字特征,包括症状变化,每日步数和临床特征,被确定为MG恶化的潜在预测因素.
- 机器学习根据症状模式确定了不同的恶化亚型.
结论:
- 使用智能手机平台进行分散的数字表型化是MG研究的一个可行的方法.
- 这种方法提供了一个多维和频繁的数据收集策略,以更好地了解MG恶化.
- 研究结果表明,数字工具有潜力通过识别其异质性来个性化MG治疗.
更多相关视频
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.3K
15:00Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
2.5K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K